K103N containing variants persist longer in women with subtype D and with higher viral loads
3 August 2006. Related: Conference reports, Drug resistance.
Conference reports
No subtype-based differences in baseline levels of K103N-containing variants in women receiving single dose nevirapine
3 August 2006. Related: Conference reports, Drug resistance.
Phenotypic NNRTI resistance and genetic diversity in antiretroviral naive women
3 August 2006. Related: Conference reports, Drug resistance.
High prevalence of the K65R mutation in Botswana patients treated with ddI/d4T-based regimens
3 August 2006. Related: Conference reports, Drug resistance.
Potential for easier selection of K65R mutation with tenofovir pressure in subtype C HIV-1 isolates
3 August 2006. Related: Conference reports, Drug resistance.
Categorisation of transmitted HIV drug resistance using the WHO/CDC HIV drug resistance threshold survey method may be useful in resource limited settings
3 August 2006. Related: Conference reports, Drug resistance.
Limitations in online tools to identify HIV-1 subtypes
3 August 2006. Related: Conference reports, Drug resistance.
Resistance implications from PrEP and microbicide studies in macaques
3 August 2006. Related: Conference reports, Drug resistance.
Low-level resistance linked to treatment failure: a role for more sensitive testing for naive patients
3 August 2006. Related: Conference reports, Drug resistance.
Testing for resistance after starting treatment
3 August 2006. Related: Conference reports, Drug resistance.
7th International Workshop on Clinical Pharmacology of HIV Therapy, 20-22 April 2006, Lisbon
11 June 2006. Related: Conference reports.
Efavirenz levels above recommended upper target in 20% of African patients in Senegal
11 June 2006. Related: Conference reports, Antiretrovirals.
Lower dose of AZT provides adequate exposure in patients with low body weight
11 June 2006. Related: Conference reports, Antiretrovirals.
Pharmacokinetics for generic fixed dose combinations for children are comparable to the branded products
11 June 2006. Related: Conference reports, Paediatric care.
Caution against dividing adult FDCs (Triomune) for young children
11 June 2006. Related: Conference reports, Paediatric care.
University of Liverpool audit of paediatric TDM
11 June 2006. Related: Conference reports, Paediatric care.
Age-dependent pharmacokinetics of 3TC in children
11 June 2006. Related: Conference reports, Paediatric care.
Use of small sample drug level monitoring for paediatric PI concentrations
11 June 2006. Related: Conference reports, Paediatric care.
Intracellular and plasma measurements of AZT and 3TC and their metabolites in neonates
11 June 2006. Related: Conference reports, Paediatric care.
Effect of pregnancy on PK of protease inhibitors
11 June 2006. Related: Conference reports, Pregnancy.
Using enzyme inducers to reduce the half-life of nevirapine
11 June 2006. Related: Conference reports.
Relationship between nevirapine concentrations and virological failure in a clinical setting
11 June 2006. Related: Conference reports, PK and drug interactions.
Summary of drug interaction studies
11 June 2006. Related: Conference reports, PK and drug interactions.
Effects of ketoconazole and rifampin on TMC278
10 June 2006. Related: Conference reports, PK and drug interactions.
Brecanavir interaction study with ritonavir and atazanavir
10 June 2006. Related: Conference reports, PK and drug interactions.
Fixed-dose formulation of efavirenz/tenofovir/FTC bioequivalent to separate dosing
10 June 2006. Related: Conference reports, Antiretrovirals.
Saquinavir/r (1000/100mg) levels reduced when taken fasted and should be taken with food
10 June 2006. Related: Conference reports, Antiretrovirals.
Lack of food effect with Meltrex formulation of lopinavir/r
10 June 2006. Related: Conference reports, Antiretrovirals.
Food interaction reduces ddI intracellular absorption and supports requirement to take fasted
10 June 2006. Related: Conference reports, Antiretrovirals.
Conflicting results on how T-20 affects tipranavir
10 June 2006. Related: Conference reports, Antiretrovirals.
12th Annual Conference of the British HIV Association, 29 March-1 April 2006, Brighton
12 May 2006. Related: Conference reports.
HIV in the UK summaries from BHIVA 12th annual conference
12 May 2006. Related: Conference reports.
Primary care practice still fails to diagnose HIV patients from high-risk groups or with symptomatic acute infection
12 May 2006. Related: Conference reports.
Use of HLA-B*5701 genetic testing to reduce abacavir hypersensitivity reactions
12 May 2006. Related: Conference reports, Side effects.
Dosing rifabutin and lopinavir/r sub-optimal rifabutin levels reported in five patients dosed according to current guidelines
12 May 2006. Related: Conference reports, PK and drug interactions, TB coinfection.
Fatal seronegative visceral leishmaniasis in Portuguese patient
12 May 2006. Related: Conference reports, Coinfections and complications.
Awareness of PEP after sexual exposure (PEPSE)
12 May 2006. Related: Conference reports.
Final reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
12 May 2006. Related: Conference reports.
Regimen durability and toxicity in 36-month follow up on ART in Khayelitsha, South Africa
12 May 2006. Related: Conference reports, Side effects.
Adults in resource-limited settings are most likely to experience an HIV-associated Illness in the first three months from initiating therapy
12 May 2006. Related: Conference reports.
Causes of death in adults receiving ARV therapy in Senegal
12 May 2006. Related: Conference reports.
Rapid scale-up of treatment in Zambia delivered at primary health level
12 May 2006. Related: Conference reports.
The effect of HIV subtype on disease progression in Rakai, Uganda
12 May 2006. Related: Conference reports.
Genital tract pharmacokinetics of ten antiretroviral drugs in HIV-positive women
12 May 2006. Related: Conference reports, Women's health.
Initiation of ART leads to a rapid decline in cervical and vaginal HIV-1 RNA
12 May 2006. Related: Conference reports, Women's health.
Effect of HSV-2 treatment on HIV-1 genital shedding and plasma viral load
12 May 2006. Related: Conference reports, Women's health.
Once-daily FTC, ddI, and efavirenz in children and adolescents
12 May 2006. Related: Conference reports, Paediatric care.
Simplified triple NRTI regimen effective in vertically infected children: two years follow-up
12 May 2006. Related: Conference reports, Paediatric care.
Long-term clinical and biological outcomes in children vertically infected with HIV
12 May 2006. Related: Conference reports, Paediatric care.
Prospective follow up of children with lipodystrophy
12 May 2006. Related: Conference reports, Paediatric care.
Tuberculosis in HIV-positive children often missed from incidence data: the influence of HAART on paediatric TB
12 May 2006. Related: Conference reports, Paediatric care, TB coinfection.
Nevirapine pharmacokinetics with infant prophylaxis
12 May 2006. Related: Conference reports, Paediatric care.
Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy
12 May 2006. Related: Conference reports, HIV prevention and transmission.
K65R frequently emerges within 1-6 weeks of tenofovir monotherapy in macaques
12 May 2006. Related: Conference reports, HIV prevention and transmission.
A genome armed against HIV
12 May 2006. Related: Conference reports, HIV prevention and transmission.
Circumcision: a surprising benefit from an unkind cut
12 May 2006. Related: Conference reports, HIV prevention and transmission.
Topical microbicides: the real front line of HIV prevention
12 May 2006. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy
3 May 2006. Related: Conference reports.
Further reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
13 April 2006. Related: Conference reports.
Pharmacokinetics of antiretrovirals in pregnancy: tenofovir, nelfinavir, lopinavir/r
13 April 2006. Related: Conference reports, Pregnancy.
Risk of central nervous system birth defects associated with ART exposure during pregnancy
13 April 2006. Related: Conference reports, Pregnancy.
No increase in adverse pregnancy outcomes in Thai women receiving nevirapine-containing HAART
13 April 2006. Related: Conference reports, Pregnancy.
ARV treatment following singe dose nevirapine exposure
13 April 2006. Related: Conference reports, Women's health.
Association of HIV replication capacity with mother to child transmission
13 April 2006. Related: Conference reports, Pregnancy.
Association between HIV subtype and detection of K103N
13 April 2006. Related: Conference reports, Pregnancy, Drug resistance.